I am a rheumatologist and epidemiologist whose research has focused primarily on risk factors for knee osteoarthritis and gout, pain mechanisms in knee osteoarthritis, as well as methodologic issues of relevance for rheumatic diseases. I have had continuous peer-reviewed foundation and NIH funding since 2003, and have over 300 peer-reviewed publications to date. I am a past chair of the FDA Arthritis Advisory Committee, serve(d) on the boards two international societies: Osteoarthritis Research Society International (OARSI) and Gout, Hyperuricemia, and Crystal-Associated Diseases Network (G-CAN), and on committees for the American College of Rheumatology (ACR) and International Association for the Study Pain (IASP), among others. My work has been recognized with the prestigious 2014 ACR Henry Kunkel Young Investigator Award for outstanding and promising independent contributions to rheumatology research (awarded to no more than one clinical researcher and/or one basic science researcher each year), and the 2022 OARSI Clinical Research Award (in recognition of important contributions to OA research). I have also engaged in developing new classification criteria for a number of rheumatic diseases. In addition to research, clinical work, and teaching, one of my key roles is to mentor trainees and junior faculty in musculoskeletal disease-related research. To that end, I was awarded the 2016 Robert Dawson Evans Research Mentoring Award. I also developed and led the new CTSI Research Career Support Program initiative, PRIME (Pathways to Research Independence and Mentoring Excellence), which aims to support early career mentored researchers to successfully transition to becoming independent researchers.
- Osteoarthritis: epidemiology; risk factors; mechanisms of osteoarthritis-related pain; the role of bone in the pathophysiology of osteoarthritis
- Gout: epidemiology; risk factors and triggers for gout attacks; management of gout; consequences of gout and hyperuricemia
- Classification criteria and outcome measures in rheumatic diseases.
- Novel methodology to address challenging epidemiologic issues
Diversity, Equity, Inclusion and Accessibility
As Chief of Rheumatology, I have launched and supported a number of DEIA-related initiatives, including as examples: monthly Section-wide JEDI (Justice, Equity, Diversity, Inclusion) meeting involving staff, trainees, and faculty at which we address DEI topics of relevance to medicine, academia, work environment, interpersonal interactions, structural/systemic policies, etc.; a standardized and structured fellowship interview process with a DEI lens; programs focused on health equity for our patients.
At the institutional level, I serve/have served on: Women's Leadership Advisory Board, Diversity & Inclusion Advisory Council, BMC's Equity Acceleratory Research Working Group ("WG4")
COVID19-related DEI activities at BUMC:
- I am co-PI with Dr. Megan Bair-Merritt on the 2022 Doris Duke Charitable Foundation COVID-19 Fund to Retain Clinical Scientists to provide support to faculty whose research was disrupted by the adverse effects of the pandemic, compounded by caregiving responsibilities. (https://www.ddcf.org/news--insights/articles/largest-us-collaborative-funding-effort-for-equity-in-biomedicine-awards-$12.1-million-in-grants/)
- In the earliest phase of the COVID-19 pandemic, our patients at BMC were among the most affected people in the city, yet pharmaceutical companies were not bringing their clinical trials to our institution. I worked closely with a multidisciplinary group, the Clinical Trials Office, and BMC leadership to bring one of the first therapeutic trials to BMC to better serve our patients, who are often from backgrounds traditionally excluded from clinical trials. We were among the highest recruiting sites, and we had the most diversity, with >80% speaking a first-language other than English
Boston University School of Public Health
Boston Medical Center
Framingham Heart Study
Arthritis & Autoimmune Diseases Research Center
Evans Center for Interdisciplinary Biomedical Research
Section Chief of Rheumatology
Boston University School of Medicine
PRROPS: Pathways of Risk and Resilience for Overlapping Pain and Sensitization
07/15/2021 - 04/30/2026 (Multi-PI)
PI: Tuhina Neogi, MD, PhDNIH/National Institute of Neurological Disorders & Stroke1R01NS121419-01
Pain in community-based older African American Adults: The Jackson Heart Study
09/30/2020 - 05/31/2025 (Multi-PI)
PI: Tuhina Neogi, MD, PhDNIH/National Institute on Aging5R01AG066914-02
CAPSITE: Community Assessment of Pain and Sensitization in the Elderly
01/01/2020 - 11/30/2024 (Multi-PI)
PI: Tuhina Neogi, MD, PhDNIH/National Institute on Aging5R01AG066010-03
Group-based mindfulness for patients with chronic low back pain in the primary care setting
09/01/2020 - 08/31/2024 (Subcontract PI)Boston Medical Center Corporation NIH NCCIH5UH3AT010621-03
CARE (Creating and Advancing Research Equity) across BUSM
10/15/2021 - 10/14/2023 (Multi-PI)
PI: Tuhina Neogi, MD, PhDDoris Duke Charitable Foundation John Templeton Fdn
Optimizing the value of pain management in knee osteoarthritis patients with comorbidities
08/01/2018 - 06/30/2023 (Subcontract PI)The Brigham and Women's Hospital, Inc. NIH NIAMS5R01AR074290-04
Wearable sensor-based Outcomes Following Physical Therapy in Knee Osteoarthritis: A Feasibility Study (WESENS-OA)
12/20/2019 - 12/31/2022 (Multi-PI)
PI: Tuhina Neogi, MD, PhDPfizer, Inc.
Evaluation of neuropathic-like symptoms and objective signs of neuropathy post-knee replacement in patient with knee osteoarthritis
12/01/2020 - 09/01/2022 (PI)Rheumatology Research Foundation
The Role of Urate in Knee Osteoarthritis-Related Inflammation, Pathology and Pain
02/01/2017 - 06/30/2022 (PI)NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases5K24AR070892-05
Pain sensitization in a trial of physical therapy for OA and meniscal tear
09/12/2019 - 08/30/2021 (Subcontract PI)The Brigham and Women's Hospital, Inc. NIH NIAMS5R21AR076156-02
Showing 10 of 28 results.
Show All Results
Phase 3 multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy
04/27/2020 - 04/27/2023 (PI)
Novartis Pharma Corp
Showing 10 of 26 results.
Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 306 results.
Thomas MJ, Guillemin F, Neogi T. Osteoarthritis Flares. Clin Geriatr Med. 2022 May; 38(2):239-257. PMID: 35410678
Kiadaliri A, Neogi T, Englund M. Gout and hospital admission for ambulatory care sensitive conditions:risks and trajectories. J Rheumatol. 2022 Apr 15.View Related Profiles. PMID: 35428711
Wallace BI, Moore MN, Heisler AC, Muhammad LN, Song J, Clauw DJ, Bingham CO, Bolster MB, Marder W, Neogi T, Wohlfahrt A, Dunlop DD, Lee YC. Fibromyalgianess and glucocorticoid persistence among patients with rheumatoid arthritis. Rheumatology (Oxford). 2022 Apr 11; 61(4):1556-1562. PMID: 34293092
Song J, Muhammad LN, Neogi T, Dunlop DD, Wohlfahrt A, Bolster MB, Bingham CO, Clauw DJ, Marder W, Lee YC. Pain sensitization as a potential mediator of the relationship between sleep disturbance and subsequent pain in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2022 Mar 31. PMID: 35358376
Neogi T, Hunter DJ, Churchill M, Shirinsky I, White A, Guermazi A, Omata M, Fountaine RJ, Pixton G, Viktrup L, Brown MT, West CR, Verburg KM. Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study. Arthritis Res Ther. 2022 Mar 29; 24(1):78.View Related Profiles. PMID: 35351194; PMCID: PMC8966257; DOI: 10.1186/s13075-022-02759-0;
Lenhard NK, Sullivan JK, Ross EL, Song S, Edwards RR, Hunter DJ, Neogi T, Katz JN, Losina E. Does Screening for Depressive Symptoms Help Optimize Duloxetine Use in Knee Osteoarthritis Patients With Moderate Pain? A Cost-Effectiveness Analysis. Arthritis Care Res (Hoboken). 2022 May; 74(5):776-789.View Related Profiles. PMID: 33253496; PMCID: PMC8164641; DOI: 10.1002/acr.24519;
Gløersen M, Steen Pettersen P, Neogi T, Jafarzadeh SR, Vistnes M, Thudium CS, Bay-Jensen AC, Sexton J, Kvien TK, Hammer HB, Haugen IK. Associations of Body Mass Index With Pain and the Mediating Role of Inflammatory Biomarkers in People With Hand Osteoarthritis. Arthritis Rheumatol. 2022 May; 74(5):810-817.View Related Profiles. PMID: 35137553; DOI: 10.1002/art.42056;
Helget LN, England BR, Roul P, Sayles H, Petro AD, Neogi T, O'Dell JR, Mikuls TR. Cause-Specific Mortality in Patients with Gout in the United States Veteran's Health Administration: A Matched Cohort Study. Arthritis Care Res (Hoboken). 2022 Mar 16. PMID: 35294114
Liew JW, Peloquin C, Tedeschi SK, Felson DT, Zhang Y, Choi HK, Terkeltaub R, Neogi T. Proton Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition in a Population-Based Study. Arthritis Care Res (Hoboken). 2022 Mar 04.View Related Profiles. PMID: 35245410
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
2022 Osteoarthritis Research Society International (OARSI):
Clinical Research Award
2021 Lund University, Sweden:
Honorary Degree: Doctor of Medicine, honoris causa
2020 Roxbury Society of Medical Information, elected member
2020 Boston University School of Medicine:
Alan S. Cohen Professor of Rheumatology (endowment)
2019 National Society of Clinical Rheumatology, elected member
2016 Boston University School of Medicine:
Robert Dawson Evans Research Mentoring Award
2014 American College of Rheumatology:
Henry Kunkel Young Investigator
2011 Osteoarthritis Research Society International:
Young Investigator Award
2009 Delta Omega Honor Society
2009 Arthritis Foundation:
J.V. Satterfield Research Award
2009 Boston University School of Medicine:
Robert Dawson Evans Junior Faculty Merit Award
1998 Alpha Omega Alpha Honor Medical Society
Available to Mentor as: (Review Mentor Role Definitions)
I have had an ongoing commitment to mentoring as evidenced by the successes of my mentees in obtaining career development grants, first-authored peer-reviewed publications, and presentations at national and international meetings. These mentoring efforts are complemented by a number of formal programs available at BUSM. Further, I helped spearhead the “Train the Mentors” program for which I served on the steering committee and act as a facilitator. I also developed and led the CTSI Research Career Support Program initiative, PRIME (Pathways to Research Independence and Mentoring Excellence), which aims to support early career mentored researchers to successfully transition to becoming independent investigators.
The majority of my mentoring activities occur within the Section of Rheumatology, which comprises a multidisciplinary team of senior faculty, junior investigators and additional staff dedicated to the conduct of research (e.g., project managers, research assistants, statistical programmers). I also serve on numerous Masters and PhD thesis committees for graduate students at the BU School of Public Health.
I received the 2016 Robert Dawson Evans Research Mentoring Award.
Co-Mentor or Peer Mentor
Research / Scholarly Mentor